doi: 10.3389/fphar.2024.1461398 Received 08 July 2024 Accepted 01 November 2024 Published 13 November 2024 Volume 15 - 2024 Edited by Daniele Maria-Ferreira, Instituto de Pesquisa Pel Pequeno Prncipe, Brazil Reviewed by Kimberly Crosby, University of Oklahoma, United States Marcelo Adrian Estrin, Interamerican Open University, Argentina Qiuxia Min, The First Peoples Hospital of Yunnan Province, China Updates Copyright 2024 Guo, Guo, Li and Wang
Involvement of unusual sites like palms or internal organs like stomach indicates systemic illness
Side effects are generally mild and rare
Candidacy is determined during your consultation and lab review
Each question requires different controls, markers, and interpretation standards
In addition, animal, observational, and genetic studies suggest benefits of GLP-1RAs in people with alcohol use disorder, although randomized trials have produced mixed results, with ongoing trials assessing their effectiveness in those with substance use disorders (SUDs) and mental illnesses